Gina Chapman - 14 Mar 2025 Form 4 Insider Report for CARGO Therapeutics, Inc. (CRGX)

Reporting relationship: President & CEO, Director
Issuer ticker: CRGX
Reported as of: 14 Mar 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Mar 2025, 16:16:18 UTC
Prior SEC filing: 20 Sep 2024
Next SEC filing: 12 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Halley Gilbert, as attorney-in-fact for Gina Chapman

Key filing fact

Gina Chapman filed Form 4 for CARGO Therapeutics, Inc. (CRGX) on 18 Mar 2025.

Key facts

This page summarizes Gina Chapman's Form 4 filing for CARGO Therapeutics, Inc. (CRGX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Mar 2025, 16:16.

Change

Previous filing in this sequence was filed on 20 Sep 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRGX transaction

Common Stock

Award

Transaction value: $0
Shares: +200,000
Change %: +192%
Price: $0.000000
Shares after: 303,905
Date: 14 Mar 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/16th of the RSUs vest on each quarterly anniversary measured from January 1, 2025 (the "Vesting Commencement Date"), such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date.